Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Phase 2B Trial of Memantine for the Treatment of Amyotrophic Lateral Sclerosis
Kasarskis, Edward
(PI)
Neuroscience Research Priority Area
Neurology
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Neuroscience
Memantine
100%
Treatment of Amyotrophic Lateral Sclerosis
100%
Amyotrophic Lateral Sclerosis
100%
Riluzole
20%
Cognitive Disorders
10%
Frontotemporal Dementia
10%
Neurodegenerative Disorder
10%
Cognitive Change
10%
Protein
10%
Complement Component C3
10%
Placebo
10%
Neurofilament
10%
Pharmacology, Toxicology and Pharmaceutical Science
Amyotrophic Lateral Sclerosis
100%
Memantine
100%
Disease Exacerbation
45%
Riluzole
18%
Drug Screening
9%
Biological Marker
9%
Cognitive Defect
9%
Protein
9%
Blindness
9%
Placebo
9%
Complement Component C3
9%
Frontotemporal Dementia
9%
Degenerative Disease
9%
Combination Therapy
9%